Spasticity Medication Guide: Which Treatment Works Best?
NeuroRehab Team
Thursday, December 11th, 2025
Multiple sclerosis patients report spasticity as a debilitating symptom, with 90% of cases showing this condition. The condition can progress beyond muscle tightness if left untreated. Patients may develop painful deformities, kyphoscoliosis, and contractures that can substantially affect their quality of life.
Cryoneurolysis for Spasticity After Stroke: What It Is & Who It Helps
NeuroRehab Team
Thursday, December 4th, 2025
Cryoneurolysis for Spasticity After Stroke: How It Works & Who It’s For
Neurological conditions bring spasticity to many patients. The numbers are striking – 80% of spinal cord injury patients, 39.5% of stroke patients with paresis, and 84% of those with multiple sclerosis experience this condition. Traditional treatments like oral anti-spasmodics and botulinum toxin injections help patients find relief, yet they have their limitations. Botulinum toxin stands as a first-line treatment for focal spasticity, but its effects last only 3-4 months before requiring another treatment.
